However, please note that this only makes sense if you tolerate dairy and use a high-quality product
While technically not a pure GLP-1 agonist, tirzepatide produces substantial weight loss (1520%) and marked metabolic improvements, with emerging evidence of significant hepatic fat reduction
By Manuel Bowman Fact-checked by Payton Olsen Last updated June 2026
Currently, the only treatment that has been shown to be effective in MASLD is a weight loss of 710%, which improves histologic fibrosis and steatosis 7
Over the following weeks, well gradually increase your dose until you reach the maximum dose of 2.4 mg, which has been shown to have positive effects on medical conditions such as fatty liver, heart disease, cholesterol levels, high blood pressure, and nonalcoholic steatohepatitis